Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Translational & Preclinical Development

New Funding Given to Network of Experimental Cancer Medicine Centres

The ECMC network will enter new partnerships to increase the availability of clinical trials for cancer patients.
Read More
Translational & Preclinical Development

Approaches to Combinational Immunotherapies: From Clinic to Approval

Our panel discussing combination therapeutics addresses challenges, modelling, and the importance of biomarkers.
Read More
Therapeutic Modalities

Antibody Discovery by Single B Cell Screening on Beacon®

On-Demand Webinar featuring Dr Amy Sheng, Technical Account Manager at Sino Biological
Read More
Therapeutic Modalities

Experts Discuss Developing Oncolytic Virus Immunotherapy

Our November Immuno-Oncology Discussion Group brought together experts in the field of oncolytic virus development to discuss engineering and translational strategies of the field
Read More
Therapeutic Modalities

What are the Key Challenges in Developing Bispecific Antibodies for Cancer Immunotherapy?

Are there too many opportunities in antibody-based immunotherapy? How do you choose your targets? How do you know when to kill a project?
Read More
Biomarkers in Immuno-Oncology

Enabling Ultrasensitive Protein Quantification with the Quanterix Homebrew Kit

Unique Homebrew Kits give researchers the flexibility to develop custom Simoa assays.
Read More
Translational & Preclinical Development

Delivering Immuno-Oncology Therapies for Solid Tumours

The panel at Immuno UK 2022 discuss the unique challenges that come with delivering immunotherapies to solid malignancies.
Read More
Therapeutic Modalities

Viral Immunotherapy: A New Approach Towards Tackling Solid Tumours

As an alternative avenue for addressing difficult-to-treat cancers, viral immunotherapies hold significant promise. CAN-2409 is well-tolerated in phase II clinical trials in patients with prostate cancer, and new applications may be on the horizon.
Read More
Tumour Microenvironment

Expert Opinions on Targeting the Tumour Microenvironment: Present Challenges and Future Outlook

The tumour microenvironment is a critical target to immuno-oncologists. Our discussion group brings together authorities in targeting the TME.
Read More

Oxford Global's R&D Key 40 Stories 2022

Download a copy of the R&D Key 40 Stories 2022 eBook today.
Read More
Therapeutic Modalities

T Cell Enhancers: Conditional Activation for a Safe and Durable Response

Crescendo Biologics’ Humabody therapeutic has the potential to address a range of issues which arise when standard monoclonal antibodies target T cell receptors, thanks to their capacity to trigger conditional immune responses.
Read More
Autoimmunity & Immunology

Immunology: from Cancer to COVID

Our panel discussion brings together experts in immunology: discussing the key areas of autoimmunity, oncology, and COVID-19.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno